Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 396Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AUCTA

02 6ACTAVIS ELIZABETH

03 6ALEMBIC

04 9ALKEM LABS LTD

05 3AMNEAL

06 6ANNORA PHARMA

07 3AUROBINDO PHARMA LTD

08 3BIONPHARMA

09 3CHARTWELL RX

10 6CIPLA

11 3GLENMARK SPECLT

12 3JUBILANT GENERICS

13 9MSN

14 9NORVIUM BIOSCIENCE

15 6NOVARTIS

16 3NOVARTIS PHARMS CORP

17 3PIRAMAL

18 3STEVENS J

19 6SUN PHARM

20 9TEVA PHARMS USA

21 3TORRENT

22 6ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 90MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 180MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 360MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 500MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 500MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

NORVIUM BIOSCIENCE

Country
Iran Expo
Not Confirmed
arrow

NORVIUM BIOSCIENCE

Country
arrow
Iran Expo
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2024-05-17

Application Number : 206585

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank